Article
Antigen-dependent interplay of formulation, systemic innate responses, and antibody responses to multi-component replicon RNA vaccination
9 Jun 2025
Abstract excerpt
Replicon RNA (repRNA) vaccines are a transformative tool in combating infectious diseases, eliciting robust immune responses at lower doses. However, systemic inflammatory responses to lipid nanoparticle (LNP)-formulated RNA vaccines may compromise safety and efficacy. repRNA vaccines delivered with cationic nanocarriers like LION offer a promising alternative by localizing innate immune responses required to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
